(Q46681670)

24 December 2017

title

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic (English)

1 reference

24 December 2017

0 references

1 reference

1 reference

Corona G

1

1 reference

24 December 2017

Mannucci E

2

1 reference

24 December 2017

Petrone L

3

1 reference

24 December 2017

Ricca V

4

1 reference

24 December 2017

Balercia G

5

1 reference

24 December 2017

Mansani R

6

1 reference

24 December 2017

Chiarini V

7

1 reference

24 December 2017

Giommi R

8

1 reference

24 December 2017

Forti G

9

1 reference

24 December 2017

Maggi M

10

1 reference

24 December 2017

publication date

1 March 2006

1 reference

24 December 2017

International Journal of Impotence Research

published in

1 reference

24 December 2017

volume

18

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

190-197

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901391

exact match

0 references

cites work

Optimizing treatment for diabetes mellitus induced erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Hypogonadism and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Steroids in adult men with type 1 diabetes: a tendency to hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Decreased androgen levels and obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Mild Hypogonadotropic hypogonadism in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Role of brain insulin receptor in control of body weight and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Depression in aging men: the role of testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

Impotence in diabetic and non-diabetic hospital outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

1 reference

7 January 2021

Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

7 January 2021

The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901391

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901391

1 reference

24 December 2017

PubMed ID

16136189

1 reference

24 December 2017